Meta-analysis finds the overall prevalence of statin intolerance is around 9% and identifies the most common risk factors.
17 Feb, 2022 | 10:07h | UTCPrevalence of statin intolerance: a meta-analysis – European Heart Journal
Commentaries:
Expert reaction to study looking at statin intolerance – Science Media Centre
Related:
Commentary on Twitter
Statin intolerance is “over-estimated and over-diagnosed”. World’s largest study shows less than 10% suffer side-effects caused by statins https://t.co/pcVk8YI3I3@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #Riskfactors pic.twitter.com/b3nFWsc74d
— European Society of Cardiology Journals (@ESC_Journals) February 16, 2022